182
Participants
Start Date
June 19, 2019
Primary Completion Date
August 24, 2020
Study Completion Date
December 31, 2025
Artemether-lumefantrine
Children will receive artemether-lumefantrine (20/120 mg) dosed according to weight (5 to \<15 kg: 1 tablet, 15 to \<25 kg: 2 tablets) at 0, 8, 24, 36, 48 and 60 hours. Medications will be administered according to the manufacturer's instructions.
Dihydroartemisinin-piperaquine
Children will receive dihydroartemisinin-piperaquine (40/320 mg) dosed according to weight (5 to \<8 kg: 1/2 tablet, 8 to \<11 kg: 3/4 tablet, 11 to \<17 kg: 1 tablet, 17 to \<25 kg: 1 1/2 tablets) at 0, 24, and 48 hours. Medications will be administered according to the manufacturer's instructions.
Tropical Diseases Research Centre, Ndola
Tropical Diseases Research Centre
UNKNOWN
Johns Hopkins Bloomberg School of Public Health
OTHER